Misoprostol For Nulliparous Women Before Hysteroscopy

Wenzhou Medical University120 enrolled

Overview

To compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.

There is no consensus on the effect of misoprostol on cervical ripening for nulliparous women. The aim of the study is to compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

120

Conditions

Cervical Ripening

Interventions

misoprostolDRUG

400ug vaginally the day before surgery

oral misoprostolDRUG

400ug misoprostol orally the day before the surgery

Eligibility

Sex: FEMALEMin age: 16 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * nulliparous women who are referred to outpatient hysteroscopy and who have given informed consent will be eligible for study recruitment. Exclusion Criteria: * women with a known allergy to misoprostol.

Locations (1)

the 1st Affiliated Hospital of Wenzhou Medical College

Wenzhou, Zhejiang, China

RECRUITING

Outcomes

Primary Outcomes

cervical width

Time frame: one day

Secondary Outcomes

side effects

Time frame: one day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.